CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Fribourg, 18 September ...

MiscellaneousFDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3 18.09.2025 / 07:00 CET/CESTMEDIA RELEASELiestal, Switzerland, 18. September 2025: ...

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European UnionOSAKA, ...

Faulty fuel cutoff switch allegedly caused plane to become a “250,000-pound lawn dart”WILMINGTON, Del.--(BUSINESS WIRE)--The families of four passengers who died in the catastrophic crash of Air India ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...

Titan Is the Timing Market's Smallest Resonator and Enables the Highest Levels of IntegrationSANTA CLARA, Calif.--(BUSINESS ...

Groundbreaking achievements include successfully grown Pigeon Primordial Germ Cells (PGCs), gene edited chicken surrogates, ...

Seasoned Leadership Joins to Support Growth and R&D and Meet Demand for Continuous Care Solution in Retinal DiseaseRALEIGH, N ...

A successful design and development process must balance exploration with structure, enabling teams to build high-quality products efficiently while adapting to change along the way. Yet, while the ...

Press releaseLuxembourg, 17 September 2025 Medicine shortages still a chronic headache for the EU 2023 and 2024 saw record levels of reported medicine shortages in EU countriesEU medicines agency ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...

Insulin pens have transformed the management of diabetes by providing a more convenient, accurate, and discreet alternative ...